The Thyroid - Too much and too little across the ages. the consequences of subclinical thyroid dysfunction

Clinical Endocrinology

Volumn 78, Issue 1, 2013, Pages 1-8

  Franklyn, Jayne A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; RADIOACTIVE IODINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

CARDIOVASCULAR SYSTEM; COGNITION; DISEASE ASSOCIATION; DISEASE SEVERITY; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; MEDICAL LITERATURE; MORBIDITY; MORTALITY; MUSCULOSKELETAL SYSTEM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SUBCLINICAL HYPERTHYROIDISM; SUBCLINICAL HYPOTHYROIDISM; THYROID FUNCTION; THYROID GLAND;

HUMANS; THYROID DISEASES; THYROID GLAND; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 84870890489     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12011     Document Type: Review

References (65)

1. Canaris, G.J., Manowitz, N.R., Mayor, G., et al. (2000) The Colorado thyroid disease prevalence study. Archives of Internal Medicine, 160, 526-534.
2. Parle, J.V., Franklyn, J.A., Cross, K.W., et al. (1993) Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. British Journal of General Practice, 43, 107-109.
3. Somwaru, L.L., Arnold, A.M., Joshi, N., et al. (2009) High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. Journal of Clinical Endocrinology and Metabolism, 94, 1342-1345.
4. Hollowell, J.G., Staehling, N.W., Flanders, W.D., et al. (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology and Metabolism, 87, 489-499.
5. Vadiveloo, T., Donnan, P.T., Cochrane, L., et al. (2011) The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism. Journal of Clinical Endocrinology and Metabolism, 96, E1-E8.
6. Wilson, S., Parle, J.V., Roberts, L.M., et al. (2006) Prevalence of subclinical thyroid dysfunction and its relation to socioeconomic deprivation in the elderly: a community-based cross-sectional survey. Journal of Clinical Endocrinology and Metabolism, 91, 4809-4816.
7. Meyerovitch, J., Rotman-Pikielny, P., Sherf, M., et al. (2007) Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians. Archives of Internal Medicine, 167, 1533-1538.
8. Parle, J.V., Franklyn, J.A., Cross, K.W., et al. (1991) Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clinical endocrinology (Oxford), 34, 77-83.
9. Parle, J.V., Maisonneuve, P., Sheppard, M.C., et al. (2001) Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet, 358, 861-865.
10. Biondi, B., Palmieri, E.A., Fazio, S., et al. (2000) Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. Journal of Clinical Endocrinology and Metabolism, 85, 4701-4705.
11. Roberts, L.M., Pattison, H., Roalfe, A., et al. (2006) Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction? Annals of Internal Medicine, 145, 573-581.
12. Kalmijn, S., Mehta, K.M., Pols, H.A., et al. (2000) Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clinical endocrinology (Oxford), 53, 733-737.
13. Van der Cammen, T.J., Mattace-Raso, F., Van, H.F., et al. (2003) Lack of association between thyroid disorders and Alzheimer's disease in older persons: a cross-sectional observational study in a geriatric outpatient population. Journal of the American Geriatrics Society, 51, 884.
14. Klein, I., &, Ojamaa, K., (2001) Thyroid hormone and the cardiovascular system. New England Journal of Medicine, 344, 501-509.
15. Pearce, E.N., Yang, Q., Benjamin, E.J., et al. (2010) Thyroid function and left ventricular structure and function in the Framingham Heart Study. Thyroid, 20, 369-373.
16. Ching, G.W., Franklyn, J.A., Stallard, T.J., et al. (1996) Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. Heart, 75, 363-368.
17. Sawin, C.T., Geller, A., Wolf, P.A., et al. (1994) Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. New England Journal of Medicine, 331, 1249-1252.
18. Auer, J., Scheibner, P., Mische, T., et al. (2001) Subclinical hyperthyroidism as a risk factor for atrial fibrillation. American Heart Journal, 142, 838-842.
19. Cappola, A.R., Fried, L.P., Arnold, A.M., et al. (2006) Thyroid status, cardiovascular risk, and mortality in older adults. JAMA, 295, 1033-1041.
20. Gammage, M.D., Parle, J.V., Holder, R.L., et al. (2007) Association between serum free thyroxine concentration and atrial fibrillation. Archives of Internal Medicine, 167, 928-934.
21. Brandt, F., Green, A., Hegedus, L., et al. (2011) A critical review and meta-analysis of the association between overt hyperthyroidism and mortality. European Journal of Endocrinology, 165, 491-497.
22. Thvilum, M., Brandt, F., Brix, T.H., et al. (2012) A review of the evidence for and against increased mortality in hypothyroidism. Nature Reviews. Endocrinology, 8, 417-424.
23. Gussekloo, J., van Exel, E., de Craen, A.J., et al. (2004) Thyroid status, disability and cognitive function, and survival in old age. JAMA, 292, 2591-2599.
24. Collet, T.H., Gussekloo, J., Bauer, D.C., et al. (2012) Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Archives of Internal Medicine, 172, 799-809.
25. Franklyn, J.A., Betteridge, J., Daykin, J., et al. (1992) Long-term thyroxine treatment and bone mineral density. Lancet, 340, 9-13.
26. Franklyn, J.A., Maisonneuve, P., Sheppard, M.C., et al. (1998) Mortality after the treatment of hyperthyroidism with radioactive iodine. New England Journal of Medicine, 338, 712-718.
27. Faber, J., &, Galloe, A.M., (1994) Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. European Journal of Endocrinology, 130, 350-356.
28. Uzzan, B., Campos, J., Cucherat, M., et al. (1996) Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. Journal of Clinical Endocrinology and Metabolism, 81, 4278-4289.
29. Cummings, S.R., Nevitt, M.C., Browner, W.S., et al. (1995) Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. New England Journal of Medicine, 332, 767-773.
30. Sheppard, M.C., Holder, R., &, Franklyn, J.A., (2002) Levothyroxine treatment and occurrence of fracture of the hip. Archives of Internal Medicine, 162, 338-343.
31. Bauer, D.C., Ettinger, B., Nevitt, M.C., et al. (2001) Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Annals of Internal Medicine, 134, 561-568.
32. Lee, J.S., Buzkova, P., Fink, H.A., et al. (2010) Subclinical thyroid dysfunction and incident hip fracture in older adults. Archives of Internal Medicine, 170, 1876-1883.
33. Surks, M.I., Ortiz, E., Daniels, G.H., et al. (2004) Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA, 291, 228-238.
34. Faber, J., Jensen, I.W., Petersen, L., et al. (1998) Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women. Clinical endocrinology (Oxford), 48, 285-290.
35. Sgarbi, J.A., Villaca, F.G., Garbeline, B., et al. (2003) The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities. Journal of Clinical Endocrinology and Metabolism, 88, 1672-1677.
36. Helfand, M., & U.S. Preventive Services Task Force. (2004) Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. [Review] [87 refs]. Annals of Internal Medicine, 140, 128-141.
37. Cooper, D.S., &, Biondi, B., (2012) Subclinical thyroid disease. Lancet, 379, 1142-1154.
38. Tunbridge, W.M., Evered, D.C., Hall, R., et al. (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clinical endocrinology (Oxford), 7, 481-493.
39. Boelaert, K., Syed, A.A., Manji, N., et al. (2009) Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidism. Clinical endocrinology (Oxford), 70, 129-138.
40. De Moraes, A.V., Pedro, A.B., &, Romaldini, J.H., (2006) Spontaneous hypothyroidism in the follow up of Graves hyperthyroid patients treated with antithyroid drugs. Southern Medical Journal, 99, 1068-1072.
41. Boelaert, K., Newby, P.R., Simmonds, M.J., et al. (2010) Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. American Journal of Medicine, 123, 183-189.
42. Lazarus, J.H., (2002) Epidemiology and prevention of thyroid disease in pregnancy. Thyroid, 12, 861-865.
43. Gammage, M.D., &, Franklyn, J.A., (1987) Amiodarone and the thyroid. The Quarterly journal of medicine, 62, 83-86.
44. Vanderpump, M.P., Tunbridge, W.M., French, J.M., et al. (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clinical endocrinology (Oxford), 43, 55-68.
45. Bell, R.J., Rivera-Woll, L., Davison, S.L., et al. (2007) Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study. Clinical endocrinology (Oxford), 66, 548-556.
46. Hueston, W.J., &, Pearson, W.S., (2004) Subclinical hypothyroidism and the risk of hypercholesterolemia. Annals of family medicine, 2, 351-355.
47. Owen, P.J., Rajiv, C., Vinereanu, D., et al. (2006) Subclinical hypothyroidism, arterial stiffness, and myocardial reserve. Journal of Clinical Endocrinology and Metabolism, 91, 2126-2132.
48. Hak, A.E., Pols, H.A., Visser, T.J., et al. (2000) Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Annals of Internal Medicine, 132, 270-278.
49. McQuade, C., Skugor, M., Brennan, D.M., et al. (2011) Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database study. Thyroid, 21, 837-843.
50. Razvi, S., Weaver, J.U., Vanderpump, M.P., et al. (2010) The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. Journal of Clinical Endocrinology and Metabolism, 95, 1734-1740.
51. Boekholdt, S.M., Titan, S.M., Wiersinga, W.M., et al. (2010) Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clinical endocrinology (Oxford), 72, 404-410.
52. Rodondi, N., den Elzen, W.P., Bauer, D.C., et al. (2010) Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA, 304, 1365-1374.
53. Rodondi, N., Newman, A.B., Vittinghoff, E., et al. (2005) Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Archives of Internal Medicine, 165, 2460-2466.
54. Rodondi, N., Bauer, D.C., Cappola, A.R., et al. (2008) Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study. Journal of the American College of Cardiology, 52, 1152-1159.
55. Meier, C., Staub, J.J., Roth, C.B., et al. (2001) TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). Journal of Clinical Endocrinology and Metabolism, 86, 4860-4866.
56. Parle, J., Roberts, L., Wilson, S., et al. (2010) A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: the Birmingham Elderly Thyroid study. Journal of Clinical Endocrinology and Metabolism, 95, 3623-3632.
57. Danese, M.D., Ladenson, P.W., Meinert, C.L., et al. (2000) Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. Journal of Clinical Endocrinology and Metabolism, 85, 2993-3001.
58. Monzani, F., Caraccio, N., Kozakowa, M., et al. (2004) Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. Journal of Clinical Endocrinology and Metabolism, 89, 2099-2106.
59. Razvi, S., Ingoe, L., Keeka, G., et al. (2007) The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. Journal of Clinical Endocrinology and Metabolism, 92, 1715-1723.
60. Krassas, G.E., Poppe, K., &, Glinoer, D., (2010) Thyroid function and human reproductive health. Endocrine Reviews, 31, 702-755.
61. Thangaratinam, S., Tan, A., Knox, E., et al. (2011) Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ, 342, d2616.
62. Haddow, J.E., Palomaki, G.E., Allan, W.C., et al. (1999) Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. New England Journal of Medicine, 341, 549-555.
63. Lazarus, J.H., Bestwick, J.P., Channon, S., et al. (2012) Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine, 366, 493-501.
64. De Groot, L., Abalovich, M., Alexander, E.K., et al. (2012) Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism, 97, 2543-2565.
65. Stagnaro-Green, A., Abalovich, M., Alexander, E., et al. (2011) Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid, 21, 1081-1125.